164 related articles for article (PubMed ID: 25548580)
1. Transient receptor potential vanilloid 1 expression and functionality in mcf-7 cells: a preliminary investigation.
Vercelli C; Barbero R; Cuniberti B; Racca S; Abbadessa G; Piccione F; Re G
J Breast Cancer; 2014 Dec; 17(4):332-8. PubMed ID: 25548580
[TBL] [Abstract][Full Text] [Related]
2. Expression and functionality of TRPV1 receptor in human MCF-7 and canine CF.41 cells.
Vercelli C; Barbero R; Cuniberti B; Odore R; Re G
Vet Comp Oncol; 2015 Jun; 13(2):133-42. PubMed ID: 23510405
[TBL] [Abstract][Full Text] [Related]
3. Expression of functional TRPV1 receptor in primary culture of canine keratinocytes.
Barbero R; Vercelli C; Cuniberti B; Della Valle MF; Martano M; Re G
J Vet Pharmacol Ther; 2018 Dec; 41(6):795-804. PubMed ID: 30043987
[TBL] [Abstract][Full Text] [Related]
4. Effects of saw palmetto extract on the vanilloid receptor TRPV1.
Yamada S; Kato Y
Low Urin Tract Symptoms; 2022 Mar; 14(2):117-121. PubMed ID: 34672430
[TBL] [Abstract][Full Text] [Related]
5. Transient receptor potential vanilloid subtype 1 mediates microglial cell death in vivo and in vitro via Ca2+-mediated mitochondrial damage and cytochrome c release.
Kim SR; Kim SU; Oh U; Jin BK
J Immunol; 2006 Oct; 177(7):4322-9. PubMed ID: 16982866
[TBL] [Abstract][Full Text] [Related]
6. Resiniferatoxin binds to the capsaicin receptor (TRPV1) near the extracellular side of the S4 transmembrane domain.
Chou MZ; Mtui T; Gao YD; Kohler M; Middleton RE
Biochemistry; 2004 Mar; 43(9):2501-11. PubMed ID: 14992587
[TBL] [Abstract][Full Text] [Related]
7. Molecular cloning, functional characterization of the porcine transient receptor potential V1 (pTRPV1) and pharmacological comparison with endogenous pTRPV1.
Ohta T; Komatsu R; Imagawa T; Otsuguro K; Ito S
Biochem Pharmacol; 2005 Dec; 71(1-2):173-87. PubMed ID: 16288992
[TBL] [Abstract][Full Text] [Related]
8. Effect of lipid raft disruption on TRPV1 receptor activation of trigeminal sensory neurons and transfected cell line.
Szoke E; Börzsei R; Tóth DM; Lengl O; Helyes Z; Sándor Z; Szolcsányi J
Eur J Pharmacol; 2010 Feb; 628(1-3):67-74. PubMed ID: 19958765
[TBL] [Abstract][Full Text] [Related]
9. 5-Iodoresiniferatoxin evokes hypothermia in mice and is a partial transient receptor potential vanilloid 1 agonist in vitro.
Shimizu I; Iida T; Horiuchi N; Caterina MJ
J Pharmacol Exp Ther; 2005 Sep; 314(3):1378-85. PubMed ID: 15947039
[TBL] [Abstract][Full Text] [Related]
10. Functional properties of the high-affinity TRPV1 (VR1) vanilloid receptor antagonist (4-hydroxy-5-iodo-3-methoxyphenylacetate ester) iodo-resiniferatoxin.
Seabrook GR; Sutton KG; Jarolimek W; Hollingworth GJ; Teague S; Webb J; Clark N; Boyce S; Kerby J; Ali Z; Chou M; Middleton R; Kaczorowski G; Jones AB
J Pharmacol Exp Ther; 2002 Dec; 303(3):1052-60. PubMed ID: 12438527
[TBL] [Abstract][Full Text] [Related]
11. Activation of transient receptor potential vanilloid 1 (TRPV1) by resiniferatoxin.
Raisinghani M; Pabbidi RM; Premkumar LS
J Physiol; 2005 Sep; 567(Pt 3):771-86. PubMed ID: 16037081
[TBL] [Abstract][Full Text] [Related]
12. TRPV1-mediated calcium signal couples with cannabinoid receptors and sodium-calcium exchangers in rat odontoblasts.
Tsumura M; Sobhan U; Muramatsu T; Sato M; Ichikawa H; Sahara Y; Tazaki M; Shibukawa Y
Cell Calcium; 2012 Aug; 52(2):124-36. PubMed ID: 22656960
[TBL] [Abstract][Full Text] [Related]
13. Direct interaction of adenosine with the TRPV1 channel protein.
Puntambekar P; Van Buren J; Raisinghani M; Premkumar LS; Ramkumar V
J Neurosci; 2004 Apr; 24(14):3663-71. PubMed ID: 15071115
[TBL] [Abstract][Full Text] [Related]
14. Sperm Release From the Oviductal Epithelium Depends on Ca(2+) Influx Upon Activation of CB1 and TRPV1 by Anandamide.
Gervasi MG; Osycka-Salut C; Sanchez T; Alonso CA; Llados C; Castellano L; Franchi AM; Villalón M; Perez-Martinez S
J Cell Biochem; 2016 Feb; 117(2):320-33. PubMed ID: 26129689
[TBL] [Abstract][Full Text] [Related]
15. Cloning and pharmacological characterization of mouse TRPV1.
Correll CC; Phelps PT; Anthes JC; Umland S; Greenfeder S
Neurosci Lett; 2004 Nov; 370(1):55-60. PubMed ID: 15489017
[TBL] [Abstract][Full Text] [Related]
16. Expression of the transient receptor potential vanilloid 1 (TRPV1) in LNCaP and PC-3 prostate cancer cells and in human prostate tissue.
Sanchez MG; Sanchez AM; Collado B; Malagarie-Cazenave S; Olea N; Carmena MJ; Prieto JC; Diaz-Laviada I I
Eur J Pharmacol; 2005 May; 515(1-3):20-7. PubMed ID: 15913603
[TBL] [Abstract][Full Text] [Related]
17. Cloning and functional characterization of dog transient receptor potential vanilloid receptor-1 (TRPV1).
Phelps PT; Anthes JC; Correll CC
Eur J Pharmacol; 2005 Apr; 513(1-2):57-66. PubMed ID: 15878709
[TBL] [Abstract][Full Text] [Related]
18. Activation of endogenous TRPV1 fails to induce overstimulation-based cytotoxicity in breast and prostate cancer cells but not in pain-sensing neurons.
Pecze L; Jósvay K; Blum W; Petrovics G; Vizler C; Oláh Z; Schwaller B
Biochim Biophys Acta; 2016 Aug; 1863(8):2054-64. PubMed ID: 27180305
[TBL] [Abstract][Full Text] [Related]
19. Pharmacology of modality-specific transient receptor potential vanilloid-1 antagonists that do not alter body temperature.
Reilly RM; McDonald HA; Puttfarcken PS; Joshi SK; Lewis L; Pai M; Franklin PH; Segreti JA; Neelands TR; Han P; Chen J; Mantyh PW; Ghilardi JR; Turner TM; Voight EA; Daanen JF; Schmidt RG; Gomtsyan A; Kort ME; Faltynek CR; Kym PR
J Pharmacol Exp Ther; 2012 Aug; 342(2):416-28. PubMed ID: 22570364
[TBL] [Abstract][Full Text] [Related]
20. Modulation of human TRPV1 receptor activity by extracellular protons and host cell expression system.
Bianchi BR; Lee CH; Jarvis MF; El Kouhen R; Moreland RB; Faltynek CR; Puttfarcken PS
Eur J Pharmacol; 2006 May; 537(1-3):20-30. PubMed ID: 16630609
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
